Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - ixazomibum - capsule rigide - ixazomibum 4 mg ut ixazomibi citras, cellulosum microcristallinum, talcum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, propylenglycolum, kalii hydroxidum, ammoniae solutio 30 per centum, e 172 (nigrum), pro capsula. - onkologikum - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - duloxetinum - capsule rigide gastroresistenti - duloxetinum 30 mg ut duloxetini hydrochloridum, sacchari sphaerae corresp. saccharum max. 100.57 mg, hydroxypropylcellulosum, hypromellosum, hypromellosi phthalas, triethylis citras, talcum, kapselhülle: hypromellosum, e 133, e 171, e 172 (nigrum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 172 (nigrum), kalii hydroxidum, pro capsula. - antidepressivo, dolore nella neuropatia diabetica, disturbo d'ansia generalizzato - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - duloxetinum - capsule rigide gastroresistenti - duloxetinum 60 mg ut duloxetini hydrochloridum 67.30 mg, sacchari sphaerae corresp. saccharum max. 201.29 mg, hydroxypropylcellulosum, hypromellosum, hypromellosi phthalas, triethylis citras, talcum, kapselhülle: hypromellosum, e 171, e 172 (nigrum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 172 (nigrum), kalii hydroxidum, pro capsula. - antidepressivo, dolore nella neuropatia diabetica, disturbo d'ansia generalizzato - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - atazanavirum - capsule - atazanavirum 150 mg ut atazanaviri sulfas, lactosum monohydricum 67.203 mg, crospovidonum, magnesii stearas, kapselhülle: gelatina, e 171, e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - le infezioni da hiv - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - atazanavirum - capsule - atazanavirum 200 mg ut atazanaviri sulfas, lactosum monohydricum 89.604 mg, crospovidonum, magnesii stearas, kapselhülle: gelatina, e 171, e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - le infezioni da hiv - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - atazanavirum - capsule - atazanavirum 300 mg ut atazanaviri sulfas 341.744 mg, lactosum monohydricum 134.406 mg, crospovidonum, magnesii stearas, kapselhülle: gelatina, e 171, e 132, e 172 (rubrum), e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - le infezioni da hiv - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - nilotinibum - capsule - nilotinibum 50 mg a nilotinibi hydrochloridum monohydricum, lactosum monohydricum 39.025 mg, crospovidonum, poloxamerum, silice colloidalis anhydrica, magnesio stearas, kapselhülle: gelatina, e-171, e 172 (giallo) e 172 (rosso), drucktinte: lacca, e 172 (nero), propylenglycolum, ammoniae soluzione del 28 per cento, per una piccola scatola. - trattamento della leucemia mieloide cronica - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

bial sa - opicaponum - capsule - opicaponum 50 mg, lactosum monohydricum 156 mg, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.714 mg, magnesii stearas, matériel de la capsule: gelatina, e 127, e 132, e 171, encre: lacca, e 171, propylenglycolum, ammoniae solutio concentrata, simeticonum pro capsula. - il morbo di parkinson - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - dutasteridum, tamsulosinum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, e 321, gelatina, glycerolum, e 171, acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: gelatina, e 171, e 172 (nigrum), e 172 (rubrum), e 172 (flavum), drucktinte: propylenglycolum, lacca, e 172 (nigrum), ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - fingolimodum - capsule - fingolimodum 0.25 mg ut fingolimodi hydrochloridum, mannitolum, hydroxypropylcellulosum, hydroxypropylbetadexum, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum pro capsula. - multiple sklerose - synthetika